A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Clinical trial NCT00641082 · COMPLETED

Trial details

NCT number: NCT00641082
Sponsor: Bukwang Pharmaceutical
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Start date: 2008-02-01
Primary completion: 2012-03-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.